Skip to main content
Clinical Trials/NCT05372796
NCT05372796
Completed
Not Applicable

Effects of Transcutaneous Occipital Nerve Stimulation and Instrument-Assisted Soft Tissue Mobilization in Chronic Migraine

Emine Atıcı1 site in 1 country45 target enrollmentSeptember 1, 2021
ConditionsMigraine

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Migraine
Sponsor
Emine Atıcı
Enrollment
45
Locations
1
Primary Endpoint
Visuel Analog Skale
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

In this study, it was aimed to examine the effects of two different treatments applied to the neck region, which have been popular in recent years, on migraine.The study included 45 female patients aged 20-50 years with migraine complaints. The patients were divided into 3 randomized groups: control group (n=15), Instrument-Assisted Soft tissue Mobilization (EDYDM) group (n=15) and on Occipital nerve TENS (OTES) group(n=15).Each group was given home exercise to their treatment. Home exercises applied 1 time per day for 5 weeks. Each exercise in the exercise program was performed with 10 repetitions

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
February 26, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Emine Atıcı
Responsible Party
Sponsor Investigator
Principal Investigator

Emine Atıcı

Principal Investigator

Okan University

Eligibility Criteria

Inclusion Criteria

  • Be between the ages of 20-50
  • International Classification of headache disorders, Third Edition (beta), using the criteria to be diagnosed with migraine without aura,
  • migraine with a history of being at least an annual,
  • VAS neck pain to be on Level 4,
  • the hit-6 score is greater than 56

Exclusion Criteria

  • receiving pharmacological or non-pharmacological treatment regularly in the last three months,
  • using a pacemaker,
  • being an epileptic or severely psychiatric patient,
  • conducting a surgical operation from the neck region,
  • cervical disc degeneration or prolapse, the presence of different diagnoses of headaches

Outcomes

Primary Outcomes

Visuel Analog Skale

Time Frame: Change from Baseline Pain at 5 weeks

VAS is a one-dimensional scale used to determine the severity of pain. The patient is asked to mark the pain he feels on a straight line of 10 cm. the value '0" means that there is no pain at all, and the value "10" means the most severe pain

Secondary Outcomes

  • SF 36(Change from baseline quality of life at 5 weeks)
  • Pittsburgh sleep quality index (PQI)(change from baseline sleep at 5 weeks)
  • Headache effect test (HIT-6)(Change from baseline headache at 5 weeks)

Study Sites (1)

Loading locations...

Similar Trials